ORPHA:488635
Early-onset epilepsy-intellectual disability-brain anomalies syndrome
Also known as: Congenital disorder of glycosylation due to PIGG deficiency · PIGG-CDG
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
17
33.9th percentile
Trials
0
Interventional, condition-specific
Researchers
220
Distinct authors in sample
Gene link
PIGG
Definitive
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare disorder of glycosylation characterized by early onset of , severe global , , and . , mild facial dysmorphism, and autistic behavior have also been reported. Brain MRI findings are variable and include cerebral atrophy, cerebellar hypoplasia/atrophy, and thin corpus callosum.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0014832
- OMIM:616917
- UMLS:C4310794
Additional Mondo synonyms (10)
GPIBD13 · MRT53 · congenital disorder of glycosylation due to PIGG deficiency · early-onset epilepsy-intellectual disability-brain anomalies syndrome · glycosylphosphatidylinositol biosynthesis defect 13 · intellectual developmental disorder, autosomal recessive 53 · intellectual disability, autosomal recessive 53 · intellectual disability, autosomal recessive type 53 · mental retardation, autosomal recessive 53 · mental retardation, autosomal recessive type 53
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.
- Gene identifiedPresent
Definitive — PIGG
- LiteraturePresent
17 matched papers (16 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (PIGG).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
17
17 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
17 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
16 in the last 10 years · high confidence · 33.9th percentile (publications denominator)
Phrase hits: 17 · MeSH hits: 0
Who's working on it?
220
Distinct author names in 17 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Jaeken J3 papers · 2023
Metabolic Center, Department of Pediatrics, University Hospitals Leuven, Herestraat 49, B-3000, Leuven, Belgium.
Papers in Europe PMC - 02Morava E3 papers · 2024
Metabolic Center, Department of Pediatrics, University Hospitals Leuven, Herestraat 49, B-3000, Leuven, Belgium. Morava-Kozicz.Eva@MAYO.edu.
Papers in Europe PMC - 03Falcão M2 papers · 2023
Institute of Hygiene and Tropical Medicine (IHMT), NOVA University Lisbon, 1349-008 Lisbon, Portugal.
Papers in Europe PMC - 04Ferreira CR2 papers · 2024
Medical Genetics Branch National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Papers in Europe PMC - 05Francisco R2 papers · 2023
UCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Lisboa, Portugal.
Papers in Europe PMC - 06Marques-da-Silva D2 papers · 2023
UCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Lisboa, Portugal.
Papers in Europe PMC - 07Mercimek-Andrews S2 papers · 2024
Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Papers in Europe PMC - 08Paprocka J2 papers · 2022
Department of Pediatric Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Papers in Europe PMC - 09Peng J2 papers · 2020
Institute for Biology and Medicine, Wuhan University of Science and Technology, Wuhan, China.
Papers in Europe PMC - 10Zhang H2 papers · 2020
Center for Reproductive Medicine, Center for Prenatal Diagnosis, First Hospital, Jilin University, Changchun 130021, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Early-onset epilepsy-intellectual disability-brain anomalies syndrome" OR "Congenital disorder of glycosylation due to PIGG deficiency" OR "Congenital disorder of the glycosylation due to PIGG deficiency" OR "PIGG-CDG" OR "GPIBD13" OR "MRT53" OR "glycosylphosphatidylinositol biosynthesis defect 13" OR "intellectual developmental disorder, autosomal recessive 53" OR "intellectual disability, autosomal recessive 53" OR "intellectual disability, autosomal recessive type 53" OR "mental retardation, autosomal recessive 53" OR "mental retardation, autosomal recessive type 53"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Early-onset epilepsy-intellectual disability-brain anomalies syndrome" OR "Congenital disorder of glycosylation due to PIGG deficiency" OR "Congenital disorder of the glycosylation due to PIGG deficiency" OR "PIGG-CDG" OR "GPIBD13" OR "MRT53" OR "glycosylphosphatidylinositol biosynthesis defect 13" OR "intellectual developmental disorder, autosomal recessive 53" OR "intellectual disability, autosomal recessive 53" OR "intellectual disability, autosomal recessive type 53" OR "mental retardation, autosomal recessive 53" OR "mental retardation, autosomal recessive type 53" OR "PIGG" OR "intellectual disability, autosomal recessive"
Recall-expansion terms: PIGG, intellectual disability, autosomal recessive
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T17:27:17.934Z